Amgen Inc. Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31)
Amgen Inc. (AMGN) reported Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) of $2.00 billion for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-27.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount · last filed 2013-02-27
- Amgen Inc. stock repurchase program, authorized amount (deprecated 2014-01-31) for the quarter ending 2012-12-31 was -$8.00B.
- Amgen Inc. stock repurchase program, authorized amount (deprecated 2014-01-31) for fiscal 2012 was $2.00B.
| Period end | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 1 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 3 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 9 month | Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) 12 month |
|---|---|---|---|---|
| 2012-12-31 | -$8.00B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $2.00B 10-K · filed 2013-02-27 | ||
| 2012-09-30 | $10.00B 10-Q · filed 2012-11-06 | |||
| 2011-10-31 | $6.10B 10-K · filed 2012-02-29 | |||
| 2011-10-13 | $6.10B 10-Q · filed 2011-11-04 | |||
| 2011-04-30 | $5.00B 10-K · filed 2012-02-29 | |||
| 2009-12-31 | $5.00B 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |